Antimicrobial resistance is a laboratory-operations problem as much as a clinical one. When susceptibility instruments extrapolate MICs instead of reading every dilution well, errors propagate into therapy decisions.
The BD Phoenix M50, per official BD documentation, reads every well of a 136-well panel using true doubling antibiotic concentrations — no extrapolated results — and demonstrates an approximately 50% lower very major error rate for Gram-negative organisms compared to bioMerieux Vitek. The 136-well design also accommodates all clinically relevant antimicrobials, cutting offline testing in an average lab by up to 71% annually.
Connected to BD Synapsys informatics, the system adds cascading antimicrobial reporting and resistance-trend tracking — the data backbone of a credible stewardship programme.
Procurement support
KRIMS Meditech Solutions supplies, installs, commissions and maintains this equipment across Africa, with manufacturer-aligned training and lifecycle service. Request a quotation for configuration, pricing and delivery.
